Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Seagen Inc.
Genmab
Servier
Eli Lilly and Company
Pfizer
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Qurient Co., Ltd.
Nouscom SRL
University of Texas Southwestern Medical Center
Novartis
M.D. Anderson Cancer Center
City of Hope Medical Center
Rutgers, The State University of New Jersey
ImmunityBio, Inc.
Novartis
Taiho Oncology, Inc.
M.D. Anderson Cancer Center
Amgen
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
The Netherlands Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Seattle Children's Hospital
Astellas Pharma Inc
Astellas Pharma Inc
Mirati Therapeutics Inc.
Merck Sharp & Dohme LLC
BioInvent International AB
Valo Therapeutics Oy
City of Hope Medical Center
University of California, Irvine
Cardiff University
Toray Industries, Inc
University of Colorado, Denver
Yonsei University
DEKA Biosciences
Compugen Ltd
Asan Medical Center
University of Colorado, Denver
Carisma Therapeutics Inc
NextCure, Inc.
Merck Sharp & Dohme LLC
National Cancer Center Hospital East